Moore Capital Management’s LumiraDx Limited Warrant LMDXW Stock Holding History

Moore Capital Management’s Portfolio LMDXW Stock Details LMDXW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-62,500	Closed	-$1.81K	–	573
2023 Q3	$1.81K	Hold	62,500	–	–	﹤0.01%	474
2023 Q2	$1.34K	Hold	62,500	–	–	﹤0.01%	502
2023 Q1	$4.93K	Hold	62,500	–	–	﹤0.01%	457
2022 Q4	$3.69K	Hold	62,500	–	–	﹤0.01%	500
2022 Q3	$7K	Hold	62,500	–	–	﹤0.01%	597
2022 Q2	$56K	Hold	62,500	–	–	﹤0.01%	487
2022 Q1	$51K	Hold	62,500	–	–	﹤0.01%	613
2021 Q4	$89K	Hold	62,500	–	–	﹤0.01%	630
2021 Q3	$79K	Buy	+62,500	New	+$72.5K	﹤0.01%	721

Other funds holding LMDXW

CVS Health Woonsocket, Rhode Island $212M AUM 19.39% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Covalent Partners Concord, Massachusetts $17.6M AUM 2.91% 1-Year Est. Return

CAM

Cresset Asset Management Chicago, Illinois $23.1B AUM 27.04% 1-Year Est. Return

Moore Capital Management's LMDXW Position: Q4 2023 in Review

Moore Capital Management sold out of LumiraDx Limited Warrant (LMDXW) in Q4 2023, closing a stake of 62,500 shares — an estimated $1.81K sold.

Moore Capital Management first reported a position in LMDXW in Q3 2021 and held it in 9 quarters. The position peaked at $89K in Q4 2021. 15 funds tracked by Wall St. Rank hold LMDXW as of Q4 2023.

Moore Capital Management reported no remaining LumiraDx Limited Warrant position as of Q4 2023 after selling out during the quarter.
Moore Capital Management sold 62,500 LumiraDx Limited Warrant shares in Q4 2023, an estimated $1.81K.
Moore Capital Management first reported a position in LumiraDx Limited Warrant in Q3 2021 and held it in 9 quarters.
Moore Capital Management's LumiraDx Limited Warrant position peaked at $89K in Q4 2021.
15 funds tracked by Wall St. Rank held LumiraDx Limited Warrant as of Q4 2023.

Based on Moore Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.